Claudin 18.2-a FAST-moving target in gastric cancer?

被引：21
|
作者：
Athauda, A.
Chau, I. [1 ]
机构：
[1] Royal Marsden Hosp, Dept Med, London, England
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷 / 05期
关键词：
1ST-LINE TREATMENT; DOUBLE-BLIND; OPEN-LABEL; CAPECITABINE; ADENOCARCINOMA; EPIRUBICIN; ZOLBETUXIMAB; OXALIPLATIN; RILOTUMUMAB; CISPLATIN;
D O I：
10.1016/j.annonc.2021.02.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：584 / 586
页数：3
相关论文
共 50 条
  • [21] Design of tracking fast-moving target depending on rotating mirror
    Wang, Guoqing
    Wang, Jincheng
    Ming, Lei
    Wang, Dongliang
    Fang, Zixuan
    Zhao, Qi
    Wang, Jingmin
    Chen, Dong
    AOPC 2019: OPTICAL SENSING AND IMAGING TECHNOLOGY, 2019, 11338
  • [22] Approach for fast-moving target detection and imaging in FMCW SAR
    Wang, Jin-Wei
    Zhou, Feng
    Wu, Yu-Feng
    Sun, Guang-Cai
    Zhang, Zi-Jing
    Dianzi Yu Xinxi Xuebao/Journal of Electronics and Information Technology, 2014, 36 (11): : 2684 - 2690
  • [23] High Prevalence of Claudin 18.2 Expression in Japanese Patients with Gastric Cancer.
    Tureci, Ozlem
    Itoh, Kyogo
    Yamaguchi, Rin
    Mukhina, Svetlana
    Sahin, Ugur
    Rohde, Christoph
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [24] Correlation of Claudin18.2 expression with clinicopathological characteristics and prognosis in gastric cancer
    Tao, Daoyu
    Guan, Bingxin
    Li, Zengxian
    Jiao, Meng
    Zhou, Chengjun
    Li, Hui
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 248
  • [25] Progress of Clinical Studies Targeting Claudin18.2 for the Treatment of Gastric Cancer
    Jin, Wu-mei
    Zhu, Yan
    Cai, Zhi-qiang
    He, Na
    Yu, Zhi-qiong
    Li, Shuang
    Yang, Ji-yuan
    DIGESTIVE DISEASES AND SCIENCES, 2024, 69 (07) : 2631 - 2647
  • [26] FDA approves first claudin-18.2-targeted antibody for gastric cancer
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (12) : 884 - 884
  • [27] Clinicopathologic Relevance of Claudin 18.2 Expression in Gastric Cancer: A Meta-Analysis
    Ungureanu, Bogdan Silviu
    Lungulescu, Cristian-Virgil
    Pirici, Daniel
    Turcu-Stiolica, Adina
    Gheonea, Dan Ionut
    Sacerdotianu, Victor Mihai
    Liliac, Ilona Mihaela
    Moraru, Emil
    Bende, Felix
    Saftoiu, Adrian
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [28] Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
    Arnold, A.
    Daum, S.
    von Winterfeld, M.
    Berg, E.
    Hummel, M.
    Rau, B.
    Stein, U.
    Treese, C.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (12): : 2357 - 2363
  • [29] QLS31905, an anti-claudin 18.2/CD3 bispecific antibody for claudin 18.2-positive gastric cancer.
    Jiang, Jiahua
    Si, Meimei
    Luo, Xiao
    Wu, Yun
    Li, Yongjun
    Yan, Xiaodan
    CANCER RESEARCH, 2022, 82 (12)
  • [30] Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
    A. Arnold
    S. Daum
    M. von Winterfeld
    E. Berg
    M. Hummel
    B. Rau
    U. Stein
    C. Treese
    Clinical and Translational Oncology, 2020, 22 : 2357 - 2363
12345